Evidence 1
Activity
Activity
6% Hemolysis
Toxicity
50 µM
Hemolytic
Cytotoxic
6% Hemolysis | 50 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae. | J Antimicrob Chemother | 2020